Researchers have significantly enhanced the performance of a surface plasmon resonance (SPR) biosensing platform by adding an atomically thin phase change material to the sensor. This plasmonic sensing device exhibits a detection limit of 1 femtomol for tumor necrosis factor (TNF alpha) biomarkers , which is more than three orders of magnitude compared to current state-of-art nanomaterial-enhanced plasmonic sensors. It also detects small biotin molecules with a sensitivity of 10 ...
